KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares OutstandingShares Repurchased
Ratios

Sarepta Therapeutics (SRPT) Shares Outstanding: 2011-2025

Historic Shares Outstanding for Sarepta Therapeutics (SRPT) over the last 8 years, with Sep 2025 value amounting to $105.4 million.

  • Sarepta Therapeutics' Shares Outstanding rose 10.39% to $105.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $105.4 million, marking a year-over-year increase of 10.39%. This contributed to the annual value of $96.9 million for FY2024, which is 3.38% up from last year.
  • Sarepta Therapeutics' Shares Outstanding amounted to $105.4 million in Q3 2025, which was up 7.18% from $98.4 million recorded in Q2 2025.
  • In the past 5 years, Sarepta Therapeutics' Shares Outstanding ranged from a high of $105.4 million in Q3 2025 and a low of $79,748 during Q1 2021.
  • For the 3-year period, Sarepta Therapeutics' Shares Outstanding averaged around $70.7 million, with its median value being $95.3 million (2024).
  • As far as peak fluctuations go, Sarepta Therapeutics' Shares Outstanding crashed by 99.90% in 2021, and later surged by 109,663.75% in 2022.
  • Over the past 5 years, Sarepta Therapeutics' Shares Outstanding (Quarterly) stood at $87,127 in 2021, then grew by 0.94% to $87,950 in 2022, then spiked by 106,474.19% to $93.7 million in 2023, then climbed by 3.38% to $96.9 million in 2024, then grew by 10.39% to $105.4 million in 2025.
  • Its Shares Outstanding was $105.4 million in Q3 2025, compared to $98.4 million in Q2 2025 and $98.3 million in Q1 2025.